Clinical Trial at MMC Gives Hope to Patients with Brain Tumor
July 27, 2016•9 min
Recurrent brain cancer, called glioblastoma multiforme (GBM) can be a life threatening condition, however, immunotherapy – which is showing tremendous promise for many cancers – is now being tested against this cancer. The trial is testing a vaccine created with the patient's own tumor tissue.Immunotherapies are treatments that restore or enhance the immune system’s natural ability to fight cancer. In just the past few years, cancer immunology has produced several new methods of treating cancer that increase the strength of immune responses against tumors. Maine Medical Center is participating in this phase II randomized trial through its participation in the Alliance for Clinical Trials in Oncology.Listen in as Christine Lu-Emerson, M.D discusses how the clinical trial at MMC gives hope to patients diagnosed with a brain tumor.